Abstract

Pain is a hallmark feature of sickle cell anemia (SCA) but management of chronic as well as acute pain remains a major challenge. Mouse models of SCA are essential to examine the mechanisms of pain and develop novel therapeutics. To facilitate this effort, we compared humanized homozygous BERK and Townes sickle mice for the effect of gender and age on pain behaviors. Similar to previously characterized BERK sickle mice, Townes sickle mice show more mechanical, thermal, and deep tissue hyperalgesia with increasing age. Female Townes sickle mice demonstrate more hyperalgesia compared to males similar to that reported for BERK mice and patients with SCA. Mechanical, thermal and deep tissue hyperalgesia increased further after hypoxia/reoxygenation (H/R) treatment in Townes sickle mice. Together, these data show BERK sickle mice exhibit a significantly greater degree of hyperalgesia for all behavioral measures as compared to gender- and age-matched Townes sickle mice. However, the genetically distinct "knock-in" strategy of human α and β transgene insertion in Townes mice as compared to BERK mice, may provide relative advantage for further genetic manipulations to examine specific mechanisms of pain.

MeSH

Cells, Anemia, Sickle Cell, Anemia, Pain, Therapeutics, Hyperalgesia, Tissues

Cited by

• Bartonella henselae infection induces a persistent mechanical hypersensitivity in mice. Rev Inst Med Trop Sao Paulo, 2021
• Sickle cell disease patient plasma sensitizes iPSC-derived sensory neurons from sickle cell disease patients. bioRxiv, 2023
• Challenges and opportunities for conceiving genetically diverse sickle cell mice. Trends Mol Med, 2025
• Sensitization of nociceptors and dorsal horn neurons contributes to pain in sickle cell disease. Neurosci Lett, 2019
• Inhibition of DAGLβ as a therapeutic target for pain in sickle cell disease. Haematologica, 2023
• β-endorphin at the intersection of pain and cancer progression: Preclinical evidence. Neurosci Lett, 2021
• Sickle cell disease iPSC-derived sensory neurons exhibit increased excitability and sensitization to patient plasma. Blood, 2024
• Genetic inactivation of calpain-1 attenuates pain sensitivity in a humanized mouse model of sickle cell disease. Haematologica, 2018
• Targeting novel mechanisms of pain in sickle cell disease. Blood, 2017
• Characterization of a mouse model of sickle cell trait: parallels to human trait and a novel finding of cutaneous sensitization. Br J Haematol, 2017
• Targeting novel mechanisms of pain in sickle cell disease. Hematology Am Soc Hematol Educ Program, 2018
• Mouse models of sickle cell disease: Imperfect and yet very informative. Blood Cells Mol Dis, 2023
• Targeting pain at its source in sickle cell disease. Am J Physiol Regul Integr Comp Physiol, 2019
• Significant Quantitative Differences in Orexin Neuronal Activation After Pain Assessments in an Animal Model of Sickle Cell Disease. Front Mol Biosci, 2020
• Analgesic effect of simultaneously targeting multiple pain processing brain circuits in an aged humanized mouse model of chronic pain by transcranial focused ultrasound. APL Bioeng, 2025
• Bivalent ligand MCC22 potently attenuates nociception in a murine model of sickle cell disease. Pain, 2019
• Neuronal transient receptor potential (TRP) channels and noxious sensory detection in sickle cell disease. Neurosci Lett, 2019
• Decitabine-Driven Foetal Haemoglobin Induction in Townes Mice and Human Erythroblasts. EJHaem, 2025
• Spatiotemporal Alterations in Gait in Humanized Transgenic Sickle Mice. Front Immunol, 2021
• Pain in sickle cell disease: current and potential translational therapies. Transl Res, 2021